newsfilter
← Latest News
GlobeNewswire·

Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion

NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for